Recombinant Rat B7-H3/CD276 Protein (Fc Tag) (PKSR030193)
                        For research use only.
| Synonyms | B7h3, CD276 | 
| Species | Rat | 
| Expression Host | HEK293 Cells | 
| Sequence | Met1-Phe244 | 
| Accession | Q7TPB4 | 
| Calculated Molecular Weight | 50.6 kDa | 
| Observed Molecular Weight | 61 kDa | 
| Tag | C-hFc | 
| Bio-activity | Not validated for activity | 
| Form | Lyophilized powder | 
| Purity | > 85 % as determined by reducing SDS-PAGE. | 
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. | 
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. | 
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. | 
| Formulation | 
      Lyophilized from sterile PBS, pH 7.4 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual.  | 
  
| Reconstitution | Please refer to the printed manual for detailed information. | 
| Background | B7-H3 is a member of the B7 family of immune regulatory ligands that is thought to attenuate peripheral immune responses through co-inhibition. It plays an important role in adaptive immune responses, and was shown to either promote or inhibit T-cell responses in various experimental systems. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is a novel protein structurally related to the B7 family of ligands by the presence of a single set of immunoglobulin-V-like and immunoglobulin-C-like (VC) domains. Previous studies have correlated its overexpression with poor prognosis and decreased tumor-infiltrating lymphocytes in various carcinomas including uterine endometrioid carcinomas, and mounting evidence supports an immuno-inhibitory role in ovarian cancer prognosis. Recently, B7-H3 expression has been reported in several human cancers indicating an additional function of B7-H3 as a regulator of antitumor immunity. | 
Other Clones
{{antibodyDetailsPage.numTotal}} Results
- 
                                    
                                    
                                    {{item.title}}
                                    
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
 
Other Formats
{{formatDetailsPage.numTotal}} Results
- 
                                    
                                    
                                    {{item.title}}
                                    
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
 
- 
                                    
                                    
IF:{{item.impact}}
Journal:{{item.journal}} ({{item.year}})
DOI:{{item.doi}}Reactivity:{{item.species}}
Sample Type:{{item.organization}}
 
- 
                                    
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
 
                            
